CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 1,200 enrolled
Drug / intervention
Peer support and mentoringbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00972699
NCT00972699Phase 2Completed

Mentor Mothers: A Sustainable Family Intervention in South African Townships

University of California, Los Angeles·interventional·Posted Sep 7, 2009·Updated May 3, 2013

In Brief

A Phase 2 clinical trial evaluating Peer support and mentoring for Human Immunodeficiency Virus and 2 related conditions. Completed, enrolled 1,200 participants across 1 site.

Detailed Summary

The purpose of this study is to test a mother-to-mother intervention during pregnancy and after delivery with Mothers Living with HIV (MLH)in South Africa. We hypothesize that the intervention will enhance the adjustment of the children of MLH by improving the health and mental health of MLH which benefits their children, as well as the MLH.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSouth Africa

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 7, 2009
Enrollment StartJul 1, 2008
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 16.8 years ago

Interventions

Peer support and mentoringbehavioral

The intervention will be delivered in 4 non consecutive visits during pregnancy and 4 visits post-partum. The sessions will be delivered to mothers living with HIV on the days of their health care appointments either individually or in groups that can accommodate up to 30 mothers living with HIV. The intervention will focus on enhancing the mother-baby relationship through increasing the health of the mother and baby, maintaining the mother's mental health, and reducing HIV transmission.